GEORGE MASON TRUST and HILLCREST TRUST – Trademark Portfolio
Entity Type: 03
GEORGE MASON TRUST and HILLCREST TRUST holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 2 (Paints) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TARATEK and PERMATEK. The owner is based in New Plymouth.
Sutton Road, R D 4
New Plymouth , NZ
Showing of trademarks Trademarks
Trademark Classifications
GEORGE MASON TRUST and HILLCREST TRUST's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GEORGE MASON TRUST and HILLCREST TRUST have?
GEORGE MASON TRUST and HILLCREST TRUST has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does GEORGE MASON TRUST and HILLCREST TRUST file in?
GEORGE MASON TRUST and HILLCREST TRUST files trademarks across 2 Nice Classification classes. The most active classes are Class 2 (Paints), Class 5 (Pharmaceuticals). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.
What are GEORGE MASON TRUST and HILLCREST TRUST's most well-known trademarks?
GEORGE MASON TRUST and HILLCREST TRUST's registered trademark portfolio includes well-known marks such as TARATEK and PERMATEK. These are among 2 currently registered trademarks in the portfolio.
What is GEORGE MASON TRUST and HILLCREST TRUST's trademark registration success rate?
GEORGE MASON TRUST and HILLCREST TRUST has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.